Adenovirus vectors containing chimeric type 5 and type 35 fiber proteins exhibit altered and expanded tropism and increase the size limit of foreign genes

被引:94
作者
Mizuguchi, H [1 ]
Hayakawa, T [1 ]
机构
[1] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan
关键词
gene therapy; adenovirus vector; fiber; retargeting;
D O I
10.1016/S0378-1119(02)00410-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Adenovirus (Ad) fiber proteins are responsible for the initial attachment of the virion to the cell membrane. Most Ad vectors currently in use are based on the Ad type 5 (Ad5), which belong to subgroup C, and use the coxsackievirus and adenovirus receptors (CAR) as the initial receptor. Ad35, which belongs to subgroup B, recognizes unknown receptor(s) other than CAR. In this study, the feasibility of the Ad vector containing Ad5/35 chimeric fiber protein was examined in a wide variety of cell types, such as CAR-positive or -negative human tumor cells, rodent cells, and blood cells (a total of 20 cell types), and in mice in vivo. Transduction data suggested that the Ad vectors containing the Ad5/35 chimeric fiber protein exhibited altered and expanded tropism when compared with the Ad5-based vector. The chimeric vector also allows the packaging of larger foreign DNAs than the conventional Ad5-based vector, which can package approximately 8.1-8.2 kb of foreign DNA. The chimeric vector containing approximately 8.8 kb of foreign DNA was generated without affecting the viral growth rate and titer. These results suggested that inclusion of the Ad35 fiber protein into the Ad5-based vector could lead to an improved efficiency in gene therapy and in gene transfer experiments, especially for the cells lacking in sufficient CAR expression. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:69 / 77
页数:9
相关论文
共 42 条
[31]   The coxsackievirus-adenovirus receptor protein can function as a cellular attachment protein for adenovirus serotypes from subgroups A, C, D, E, and F [J].
Roelvink, PW ;
Lizonova, A ;
Lee, JGM ;
Li, Y ;
Bergelson, JM ;
Finberg, RW ;
Brough, DE ;
Kovesdi, I ;
Wickham, TJ .
JOURNAL OF VIROLOGY, 1998, 72 (10) :7909-7915
[32]   Adenovirus types 11p and 35p show high binding efficiencies for committed hematopoietic cell lines and are infective to these cell lines [J].
Segerman, A ;
Mei, YF ;
Wadell, G .
JOURNAL OF VIROLOGY, 2000, 74 (03) :1457-1467
[33]   Efficient gene transfer into human CD34+ cells by a retargeted adenovirus vector [J].
Shayakhmetov, DM ;
Papayannopoulou, T ;
Stamatoyannopoulos, G ;
Lieber, A .
JOURNAL OF VIROLOGY, 2000, 74 (06) :2567-2583
[34]  
Shenk T., 1996, FIELDS VIROLOGY, V2, P2111
[35]   Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein [J].
Stevenson, SC ;
Rollence, M ;
MarshallNeff, J ;
McClelland, A .
JOURNAL OF VIROLOGY, 1997, 71 (06) :4782-4790
[36]   HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses [J].
Tomko, RP ;
Xu, RL ;
Philipson, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3352-3356
[37]   Targeting adenovirus [J].
Wickham, TJ .
GENE THERAPY, 2000, 7 (02) :110-114
[38]   Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins [J].
Wickham, TJ ;
Tzeng, E ;
Shears, LL ;
Roelvink, PW ;
Li, Y ;
Lee, GM ;
Brough, DE ;
Lizonova, A ;
Kovesdi, I .
JOURNAL OF VIROLOGY, 1997, 71 (11) :8221-8229
[39]   INTEGRIN-ALPHA-V-BETA-3 AND INTEGRIN-ALPHA-V-BETA-5 PROMOTE ADENOVIRUS INTERNALIZATION BUT NOT VIRUS ATTACHMENT [J].
WICKHAM, TJ ;
MATHIAS, P ;
CHERESH, DA ;
NEMEROW, GR .
CELL, 1993, 73 (02) :309-319
[40]   Biodistribution of an adenoviral vector carrying the luciferase reporter gene following intravesical or intravenous administration to a mouse [J].
Wood, M ;
Perrotte, P ;
Onishi, E ;
Harper, ME ;
Dinney, C ;
Pagliaro, L ;
Wilson, DR .
CANCER GENE THERAPY, 1999, 6 (04) :367-372